These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas. Hernandez L; Fest T; Cazorla M; Teruya-Feldstein J; Bosch F; Peinado MA; Piris MA; Montserrat E; Cardesa A; Jaffe ES; Campo E; Raffeld M Blood; 1996 Apr; 87(8):3351-9. PubMed ID: 8605352 [TBL] [Abstract][Full Text] [Related]
4. p53 overexpression as a marker of poor prognosis in mantle cell lymphomas with t(11;14)(q13;q32). Louie DC; Offit K; Jaslow R; Parsa NZ; Murty VV; Schluger A; Chaganti RS Blood; 1995 Oct; 86(8):2892-9. PubMed ID: 7579380 [TBL] [Abstract][Full Text] [Related]
5. Deletions and loss of expression of p16INK4a and p21Waf1 genes are associated with aggressive variants of mantle cell lymphomas. Pinyol M; Hernandez L; Cazorla M; Balbín M; Jares P; Fernandez PL; Montserrat E; Cardesa A; Lopez-Otín C; Campo E Blood; 1997 Jan; 89(1):272-80. PubMed ID: 8978301 [TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic study of PRAD1/cyclin D1 overexpressing lymphoma with special reference to mantle cell lymphoma. A distinct molecular pathologic entity. Yatabe Y; Nakamura S; Seto M; Kuroda H; Kagami Y; Suzuki R; Ogura M; Kojima M; Koshikawa T; Ueda R; Suchi T Am J Surg Pathol; 1996 Sep; 20(9):1110-22. PubMed ID: 8764748 [TBL] [Abstract][Full Text] [Related]
7. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features. Rasmussen PK Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159 [TBL] [Abstract][Full Text] [Related]
8. Mantle cell lymphomas lack expression of p27Kip1, a cyclin-dependent kinase inhibitor. Quintanilla-Martinez L; Thieblemont C; Fend F; Kumar S; Pinyol M; Campo E; Jaffe ES; Raffeld M Am J Pathol; 1998 Jul; 153(1):175-82. PubMed ID: 9665478 [TBL] [Abstract][Full Text] [Related]
9. CD5-expressing B-cell non-Hodgkin's lymphomas with bcl-1 gene rearrangement have a relatively homogeneous immunophenotype and are associated with an overall poor prognosis. Segal GH; Masih AS; Fox AC; Jorgensen T; Scott M; Braylan RC Blood; 1995 Mar; 85(6):1570-9. PubMed ID: 7534138 [TBL] [Abstract][Full Text] [Related]
10. [Pathologic diagnosis of mantle cell lymphoma based on histologic, cytologic, immunohistologic and genetic characteristics]. László T; Csernus B; Krenács L; Kelényi G; Matolcsy A Orv Hetil; 1999 Dec; 140(52):2907-12. PubMed ID: 10659642 [TBL] [Abstract][Full Text] [Related]
11. p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis. Greiner TC; Moynihan MJ; Chan WC; Lytle DM; Pedersen A; Anderson JR; Weisenburger DD Blood; 1996 May; 87(10):4302-10. PubMed ID: 8639789 [TBL] [Abstract][Full Text] [Related]
12. Expression of cell cycle regulating proteins in an unusual transformation of mantle cell lymphoma. Tamaru J; Kawana H; Takahashi Y; Takahashi N; Isobe K; Hirai A; Saito Y; Harigaya K; Itoyama S; Mikata A Leuk Lymphoma; 1999 Dec; 36(1-2):129-37. PubMed ID: 10613457 [TBL] [Abstract][Full Text] [Related]
13. Immunophenotypic Characterization of Canine Splenic Follicular-Derived B-Cell Lymphoma. Stein L; Bacmeister C; Ylaya K; Fetsch P; Wang Z; Hewitt SM; Kiupel M Vet Pathol; 2019 May; 56(3):350-357. PubMed ID: 30636524 [TBL] [Abstract][Full Text] [Related]
14. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct. Matolcsy A; Chadburn A; Knowles DM Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611 [TBL] [Abstract][Full Text] [Related]
15. SOX11 is useful in differentiating cyclin D1-positive diffuse large B-cell lymphoma from mantle cell lymphoma. Hsiao SC; Cortada IR; Colomo L; Ye H; Liu H; Kuo SY; Lin SH; Chang ST; Kuo TU; Campo E; Chuang SS Histopathology; 2012 Oct; 61(4):685-93. PubMed ID: 22642745 [TBL] [Abstract][Full Text] [Related]
16. Proliferative fraction, bcl-1 gene translocation, and p53 mutation status as markers in mantle cell lymphoma. Fiel-Gan MD; Almeida LM; Rose DC; Takano A; Rezuke WN; Coleman WB; Garcia NF; Tsongalis GJ Int J Mol Med; 1999 Apr; 3(4):373-9. PubMed ID: 10085408 [TBL] [Abstract][Full Text] [Related]